Effectiveness of the Epley Manoeuvre Performed in Primary Care to Treat Benign Paroxysmal Positional Vertigo
Benign Positional Paroxysmal Vertigo
About this trial
This is an interventional treatment trial for Benign Positional Paroxysmal Vertigo focused on measuring Vestibular Diseases, Vertigo, Primary care, Epley maneuver
Eligibility Criteria
INCLUSION CRITERIA
- Patients aged 18 years and older who attend our primary care centre, with suspected diagnosis of BPPV, and present vertigo or nystagmus with DH manoeuvre. All other causes of vertigo will be ruled out.
- Written informed consent will be obtained from all subjects of both intervention group and control group prior to its inclusion in the study.
EXCLUSION CRITERIA
- Previous or current diagnoses of labyrinth's diseases such as Meniere's disease, labyrinthitis or vestibular neuronitis.
- Contraindications to canalith repositioning procedures: cervical spinal stenosis, severe kyphoscoliosis, limited cervical mobility, Down syndrome, advanced rheumatoid arthritis, cervical radiculopathies, Paget's disease, morbid obesity, ankylosing spondylitis, severe lumbar dysfunction and spinal cord injuries.
- Pregnancy or breastfeeding.
- Contraindications of betahistine.
- Refusal of patients to participate in the study.
Sites / Locations
- CAP Florida
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
INTERVENTION ARM
CONTROL GROUP
Patients meeting the inclusion criteria will be randomly assigned to the experimental group. They will receive Epley's manoeuvre plus betahistine 8mg three times a day until they no longer have symptoms. The Epley's manoeuvre will be performed only on the first visit.
Patients meeting the inclusion criteria will be randomly assigned to the control group. These patients will receive sham manoeuvre (simulated Epley manoeuvre) plus betahistine 8mg three times a day until they no longer have symptoms. Placebo manoeuvre is performed with the patient lying down over the affected side for 5 minutes as it is described in similar studies.